Do Son Neuralink has joined an AI-powered "Smart Bionic Eye" research initiative led by UCSB, aiming to restore sight to the blind by integrating brain-computer interface technology.
Clinical Trials
Isomorphic Labs (Google DeepMind's subsidiary) announced its first AI-designed drug is ready for clinical trials, marking a historic milestone in AI-driven pharmaceutical development.